ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
A judge has approved a $56 million settlement in a class action alleging Monash IVF destroyed potentially viable embryos, including a $10.6 million payout for the firm that ran the case.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.
A class action against Toyota Finance has argued it can add new claims that are out of time because Victorian courts cannot factor in the loss of limitations defences in deciding whether to allow amendments.
Graincorp may face new allegations in a class action that the use of n-Hexane at an oilseed factory in rural Victoria had an impact on the health of local residents.